JPS6474990A - Vector, recombinant dna, virus and production of protein - Google Patents
Vector, recombinant dna, virus and production of proteinInfo
- Publication number
- JPS6474990A JPS6474990A JP62231107A JP23110787A JPS6474990A JP S6474990 A JPS6474990 A JP S6474990A JP 62231107 A JP62231107 A JP 62231107A JP 23110787 A JP23110787 A JP 23110787A JP S6474990 A JPS6474990 A JP S6474990A
- Authority
- JP
- Japan
- Prior art keywords
- gene
- nuclear
- protein
- virus
- recombinant dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PURPOSE:To mass produce HIV antigen protein, by integrating a manifestation vector of DNA of nuclear polyhedroisis virus of silkworm with a gene of HIV antigen active protein and using the prepared recombinant DNA. CONSTITUTION:A gene of gag, pol, SOR gp120 or gp41 of HIV is integrated into a polylinker range of transfer vector pBFs containing a promoter range of a polyhedron protein structure gene of DNA of nuclear polyhedroisis virus silkworm to construct recombinant DNA. A recombinant nuclear polyhedroisis virus infected with the recombinant DNA is multiplied nuclear in a culture cell or host to give a large amount of HIV antigen protein. Plasmid pBFs can be constructed from plasmid pBmE36 containing EcoRI-EcoRI fragment of polyhedron gene of silkworm, contains ATG code, a signal of a protein synthesis initiator of nuclear polyhedron gene and has a polylinker and a termination codon TAA of polyhedron gene after the ATG code.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62231107A JPS6474990A (en) | 1987-09-17 | 1987-09-17 | Vector, recombinant dna, virus and production of protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62231107A JPS6474990A (en) | 1987-09-17 | 1987-09-17 | Vector, recombinant dna, virus and production of protein |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6474990A true JPS6474990A (en) | 1989-03-20 |
Family
ID=16918409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62231107A Pending JPS6474990A (en) | 1987-09-17 | 1987-09-17 | Vector, recombinant dna, virus and production of protein |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6474990A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS619288A (en) * | 1984-06-21 | 1986-01-16 | Dai Ichi Seiyaku Co Ltd | Preparation of peptide |
JPS61173782A (en) * | 1984-10-31 | 1986-08-05 | カイロン・コーポレイション | Recombinant virus protein relating to lymph node disease syndrome and/or acquired immunodeficient syndrome |
-
1987
- 1987-09-17 JP JP62231107A patent/JPS6474990A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS619288A (en) * | 1984-06-21 | 1986-01-16 | Dai Ichi Seiyaku Co Ltd | Preparation of peptide |
JPS61173782A (en) * | 1984-10-31 | 1986-08-05 | カイロン・コーポレイション | Recombinant virus protein relating to lymph node disease syndrome and/or acquired immunodeficient syndrome |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Accola et al. | Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6 gag | |
Paxton et al. | Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis | |
Connor et al. | Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes | |
Liu et al. | Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys | |
IE800991L (en) | HBs Ag GENE AND PRODUCT | |
Zur Megede et al. | Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene | |
WO2001081608A3 (en) | Viral vectors for use in monitoring hiv drug resistance | |
ATE291632T1 (en) | LENTIVIRUS-BASED GENE TRANSFER VECTORS | |
Schønning et al. | Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1 | |
EP0265785A3 (en) | Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells | |
CA2370103A1 (en) | Method and means for producing high titer, safe, recombinant lentivirus vectors | |
ES8706208A1 (en) | Expression of immunologically reactive viral proteins. | |
Zhang et al. | Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly | |
AU588462B2 (en) | Non-cytopathic clone of human t-cell lymphotropic virus type iii | |
Zhao et al. | Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIVmac251 challenge by a replication-competent Ad5hr-SIV env/rev and Ad5hr-SIV gag recombinant priming/gp120 boosting regimen | |
CN101353666B (en) | HIV medicament screening cell model and special pseudotype lentivirus therefor | |
Digilio et al. | The simian T-lymphotropic/leukemia virus from Pan paniscus belongs to the type 2 family and infects Asian macaques | |
DUCLOS et al. | Cytomegalovirus infection and trans-activation of HIV-1 and HIV-2 LTRs in human astrocytoma cells | |
EP0152030A3 (en) | Adult t cell leukemia virus antigen polypeptide | |
JPS6474990A (en) | Vector, recombinant dna, virus and production of protein | |
Mautino et al. | Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev | |
D’Costa et al. | Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation | |
EP0255242A3 (en) | Oncornavirus vaccines | |
GOEPFERT et al. | Analysis of west African hunters for foamy virus infections | |
Jones et al. | A 100-amino acid truncation in the cytoplasmic tail of glycoprotein 41 in the reference HIV type 1 strain RF |